The stock has demonstrated a strong overall uptrend over the past six months, with a price increase of 44.42% from around $490 in early October 2025 to $708.46 as of March 31, 2026. This performance significantly outpaces the broader market, as evidenced by a relative strength of 47.24% against the S&P 500 over the same period. In the short term, the stock has shown volatility, declining 4.63% over the past month but gaining 23.67% over the past three months. The one-month decline was less severe than the S&P 500's 5.25% drop, resulting in positive relative strength of 0.62%. The price surged from a low near $490 in October to a peak above $775 in February before pulling back. The current price of $708.46 sits within the upper half of its 52-week range of $267.30 to $789.81, representing approximately 89% of the yearly high. This indicates the stock is trading near recent highs despite the recent pullback from its February peak.

Revenue for Q4 2025 was $19.13 billion, representing 18% year-over-year growth from the same quarter in 2024. However, profitability metrics showed some pressure; the net income margin for Q4 2025 was 12.55%, down from 17.21% in Q4 2024, and quarterly net income declined from $2.79 billion to $2.40 billion year-over-year. The company maintains a strong cash position with $9.99 billion in cash at the end of Q4 2025 and generated robust free cash flow of $10.27 billion over the trailing twelve months. However, financial leverage is elevated with a debt-to-equity ratio of 2.03, indicating significant use of debt financing. Return on Equity (ROE) is exceptionally high at 41.62%, reflecting efficient use of shareholder capital, partly amplified by the high financial leverage. The current ratio of 1.44 suggests adequate short-term liquidity to cover obligations.